Summary of Conference Call on Insurance Sector Industry Overview - The insurance sector has recently experienced a notable correction, with the A and H insurance indices declining by 6.2% and 2.2% respectively over the past five days, and major insurance stocks in the AH market dropping between 2% and 4% on the 26th [1][1]. Core Points and Arguments 1. **Short-term Adjustment Factors**: - **AI Panic Transmission**: A recent report on AI crisis has circulated, suggesting potential collapse of the white-collar class and traditional financial business models, which contributed to a significant drop in US stocks on the 23rd, subsequently affecting AH insurance stocks [1][1]. - **Market Liquidity Pressure**: Following the holiday, strong performance in cyclical resources and technology growth sectors has put pressure on the insurance sector, leading to weaker performance among key stocks [1][1]. - **Pessimistic Earnings Expectations**: There are concerns regarding the annual reports of insurance stocks, with expectations of slight pressure on investment returns due to the Q4 growth stock pullback and rising interest rates, leading to a pessimistic outlook for Q4 net profit [2][2]. 2. **Positive Outlook for the Insurance Sector**: - **Overstated AI Concerns**: The panic regarding AI is considered overblown, as the domestic financial system remains stable and regulatory measures are strict. The application of AI is viewed more as an opportunity than a threat [2][2]. - **Net Profit Volatility**: Short-term fluctuations in net profit are not expected to impact the actual value of life insurance businesses. The anticipated recovery in the growth sector in Q1 2026 is expected to stabilize investment performance [2][2]. - **High Demand and Low Valuation**: The insurance sector is experiencing high demand for products amid a "deposit migration" trend. The leading insurance companies have shown impressive growth in new single premium policies since the start of 2026, with a notable increase in the proportion of participating insurance, which helps mitigate interest margin risks [2][2]. 3. **Long-term Investment Value**: The recent correction has further emphasized the low valuation of the insurance sector, reinforcing the belief in its long-term investment potential [3][3].

Core Viewpoint - The narrative surrounding AI has led to a decline in domestic and foreign insurance stocks, primarily due to concerns over interest rate predictions and the sustainability of insurance companies' business models. However, the company believes that the potential negative impacts have been exaggerated, and the opportunities in the insurance sector outweigh the challenges, maintaining that the industry is in a significant opportunity period [1]. Group 1: Market Dynamics - Since early 2026, insurance stocks have experienced a notable correction, influenced by factors such as the stock market decline in Q4 2025 affecting 2025 annual reports, increased ETF volumes leading to funding pressures, and AI narratives causing emotional concerns [1]. - From an interest rate perspective, insurance stocks benefit from the steepening of China's bond yield curve. The company anticipates that China's fiscal deficit will be around 4% in 2026, with long-term bond supply remaining high. In a loose monetary policy environment, the bond yield curve is expected to continue its steepening trend observed since 2025 [1]. - The company projects that due to the unclear real estate situation and low CPI, interest rates in China will likely remain low for an extended period. Leading insurance companies are actively selling policies during this phase, expanding low-cost liabilities through dividend insurance and bank insurance channels, thus enjoying the benefits of term spreads [1]. Group 2: AI Impact on Insurance Value Chain - The company identifies six attributes that redefine the insurance value chain in the AI era, including necessity, amount, human behavior, frequency, service requirements, and trust requirements. The key is to balance human weaknesses (such as procrastination and optimism bias) with risk management needs. Products that counter human tendencies require stronger trust intermediaries and scenario-triggered mechanisms [2]. - AI applications present more opportunities than challenges for both tech companies and traditional insurers, given China's relatively low insurance penetration and diverse customer needs [2]. Group 3: Traditional vs. Tech Insurance Companies - Traditional insurance companies possess a strong competitive advantage, particularly in areas requiring long-term trust and complex service demands. They can continue to invest in extending their value into the physical world and human relationships, while also integrating technology to enhance standardization and data-driven processes [4]. - Tech companies have potential breakthroughs in various combinations of insurance products, including high-risk, scale, barrier, and flow combinations, each with specific characteristics and market opportunities [3]. Group 4: Investment Strategy and Regulatory Environment - The insurance sector is still in a significant opportunity period, with the adjustment of AI narratives creating a right-side investment window. Over the next 3-5 years, insurance companies are expected to benefit from a highly regulated and competitive environment, with market share likely to continue concentrating among the top seven companies [6]. - Regulatory policies are pushing the industry to strengthen asset-liability management and encourage insurance companies to participate as strategic investors in large-scale equity offerings. These policies are expected to act as catalysts for insurance stock prices [7].

Group 1 - The core index, the CSI Guangdong-Hong Kong-Macao Greater Bay Area Development Theme Index (931000), has seen a decline of 0.79% as of February 27, 2026 [1] - Among the constituent stocks, Huatai Medical led with a gain of 1.53%, while Yingweike experienced the largest drop at 4.12% [1] - The Greater Bay Area ETF (512970) is currently experiencing a stalemate, with a latest quote of 0 yuan, and has accumulated a rise of 0.86% over the past two weeks [1] Group 2 - The Greater Bay Area ETF closely tracks the CSI Guangdong-Hong Kong-Macao Greater Bay Area Development Theme Index, which reflects the overall performance of listed companies benefiting from the Greater Bay Area development [2] - As of January 30, 2026, the top ten weighted stocks in the index include China Ping An, Luxshare Precision, BYD, and others, accounting for a total of 44.55% of the index [2] - The index includes a maximum of 50 Hong Kong market securities, 300 companies from the Shanghai-Hong Kong-Shenzhen markets, and 100 mainland market securities that align with the Greater Bay Area development theme [2]

Group 1 - The restructuring of the international monetary order will remain a key theme for global assets in 2026, with trends supporting a bull market for Chinese stocks and gold, and favoring Chinese stocks over US stocks [1] Group 2 - In the domestic blood products industry, the proportion of domestic albumin batch approvals is increasing, with stable performance in albumin, immunoglobulin, and fibrinogen approvals expected in 2025 [2] - The growth rate of approvals for VIII factor and PCC is rapid, while the approvals for certain products like immunoglobulin are also showing good growth [2] - Companies are focusing on the development of recombinant products and new immunoglobulins, with ongoing research and development efforts [2] - The blood products industry in 2026 should focus on plasma station expansion, industry mergers and acquisitions, and progress in new product development [2] Group 3 - The insurance sector is expected to continue benefiting from strict regulations and a competitive environment over the next 3-5 years, leading to increased market share concentration among major players [3] - The low interest rate environment is driving savings deposits towards insurance companies, creating a win-win situation for banks, insurance companies, and customers, which is likely to persist long-term [3] - There is high certainty for growth in policy sales, investment income, and profits in 2026, especially given the low base in 2025, with recent adjustments in AI narratives providing investment opportunities [3]

Core Viewpoint - The establishment of Zhongbao Investment Zhixing An (Jiaxing) Equity Investment Partnership (Limited Partnership) marks a significant development in the equity investment sector, with a registered capital of 500 million RMB and a focus on equity and venture investments [1]. Company Information - Company Name: Zhongbao Investment Zhixing An (Jiaxing) Equity Investment Partnership (Limited Partnership) [1] - Executing Partner: Li Yihuan [1] - Registration Status: Open [1] - Establishment Date: February 26, 2026 [1] - Unified Social Credit Code: 91330402MAK67WQA14 [1] - Registered Capital: 500 million RMB [1] - Business Duration: February 26, 2026, to February 25, 2034 [1] - Company Type: Limited Partnership [1] - Main Business Location: No. 220, Building 1, Fund Town, Nanjing Road, Dongzha Street, Nanhu District, Jiaxing City, Zhejiang Province [1] Business Scope - General Projects: Equity investment; venture investment (limited to investments in unlisted companies) [1]. Partner Information - Partner 1: Yong'an Property Insurance Co., Ltd. (State-owned) [1] - Partner 2: China Insurance Investment Co., Ltd. [1]

Group 1: China Ping An - The core strategy of China Ping An is "comprehensive finance + medical care and elderly care," which aims to create a new value growth pole through a "product + service" model, leading to long-term stable profit growth [3][4] - The report suggests that the current market valuation of China Ping An is low, with a PEV of 0.75, and recommends a target market value of 1.6 trillion yuan, corresponding to a target price of 88.53 yuan per share [3][4] - The aging population in China and the increasing importance of commercial health insurance in medical payments are expected to enhance the effectiveness of the "product + service" model, positioning it as a new growth driver for the company [3][4] Group 2: Steel Research High Temperature Alloy - Steel Research High Temperature Alloy is a leading company in the high-temperature alloy sector, benefiting from strong demand in the aerospace industry and the trend towards technological self-sufficiency [5][6] - The company is expected to achieve steady growth in net profit, with forecasts of 132 million yuan, 152 million yuan, and 172 million yuan for 2025 to 2027, respectively [5][6] - The report highlights the resilience of the high-temperature alloy industry, driven by increasing defense budgets and the upgrade of aerospace equipment, which supports long-term demand [6][7] Group 3: CSPC Pharmaceutical Group - CSPC Pharmaceutical Group is recognized for its strong innovation capabilities, with a focus on oncology and chronic disease treatment pipelines, and has established an international business development ecosystem [8][9] - The company has entered a strategic collaboration with AstraZeneca to develop innovative long-acting peptide drugs, which is expected to generate significant revenue potential [9][10] - The report predicts EPS growth of 48%, 36%, and -7% for 2025 to 2027, with a target price of 16.58 HKD per share [8][9] Group 4: Real Estate Market - The real estate market in China is currently in a deep adjustment phase, with only 19% of cities showing signs of bottoming out as of Q4 2025 [18][19] - New home prices are experiencing significant fluctuations, particularly in first-tier cities, while second-hand home prices are generally declining [19][20] - The report indicates that the inventory clearance cycle is extending, with first-tier cities reaching 19-28 months and some second-tier cities exceeding 38 months [20] Group 5: Robotics and Automation - The company is actively expanding into the humanoid robotics sector, with new product launches expected to drive growth [21][22] - The report forecasts EPS of 1.14, 1.47, and 1.83 yuan for 2025 to 2027, with a target price of 147.00 yuan per share [21][22] - The company is leveraging its expertise in micro-drive systems to enhance its competitive position in the robotics market [22][23] Group 6: Energy Storage Sector - The energy storage sector is anticipated to see significant growth, with the introduction of capacity pricing mechanisms in provinces like Qinghai [36][37] - The report suggests that the demand for energy storage systems and batteries will increase, recommending several key stocks in this sector [36][37] - The expected growth rate for energy storage demand in 2026 is projected to be around 50% [38]

Core Viewpoint - The insurance industry is expected to benefit from strict regulations and a competitive environment over the next 3-5 years, leading to increased market share concentration among the top seven companies [1] Group 1: Market Dynamics - The low interest rate environment is driving a migration of savings deposits to insurance companies, resulting in a win-win situation for banks, insurance companies, and customers [1] - This trend is anticipated to continue long-term, supporting capital patience and bolstering the development of the stock and bond markets as well as the real economy [1] Group 2: Regulatory Environment - Ongoing regulatory efforts are pushing the industry to enhance asset-liability management and advance the construction of the second and third phases of solvency regulations [1] - Smaller insurance companies are encouraged to reduce scale while improving quality, and insurance companies are being incentivized to act as strategic investors in large-scale equity financing for listed companies [1] - The southbound trading scheme is expected to increase its quota, allowing insurance companies to allocate more towards overseas high-yield bonds, with these policies acting as catalysts for stock prices in the insurance sector [1] Group 3: Future Outlook - For the first quarter and mid-year reports of 2026, there is a high certainty of growth in policy sales, investment returns, and profits based on a low base in 2025 [1] - Recent adjustments in AI narratives have created an investment window, with a recommendation to focus on leading companies that exhibit rapid growth in new business value, stable profitability and dividends, and low valuations [1]

当投保人高某因确诊胃癌向保险公司申请重大疾病保险金时，他收到了解除合同并拒赔的通 知，理由是其投保时未如实告知的健康异常：一是病历中记载的"2015年于武汉某医院行甲 状腺肿瘤手术"，二是2021年被诊断的"轻度慢性浅表性胃炎"。 然而，高某提交的甲状腺彩超检查报告单及门诊病历显示，他未曾进行过甲状腺肿瘤手术。 此外，入院记录记载的"武汉某医院"在现实中并不存在。 日前，湖北省鄂州市中级人民法院对该案作出终审判决，撤销一审驳回原告诉求的判决，判 令君龙人寿保险有限公司（以下简称"君龙人寿）于判决生效后十日内向投保人高某支付保 险金13万元。 值得注意的是，这并非个案。在黑猫投诉 【下载黑猫投诉客户端】平台上，有多起针对该 公司的相关投诉，投诉内容核心围绕保险拒赔、条款不明、理赔沟通不畅等。 投保恶性肿瘤险 确诊后却遭拒赔 据裁判文书网披露，2023年5月6日，投保人高某通过线上渠道，向某保险公司投保了"君龙 孝心保恶性肿瘤疾病保险（互联网）"。 新浪金融曝光台经查询保险产品备案信息核实，该款保险产品的承保主体为君龙人寿保险有 限公司。 （图源：国家金融监 督管理总局官网） 根据保险合同约定，被保险人与受益人均 ...

Core Viewpoint - The 2026 "Zhengzhou Medical Insurance" will officially launch on February 28, 2026, introducing new benefits aimed at reducing the medical burden on insured individuals while maintaining existing coverage options [1] Group 1: Program Overview - The "Zhengzhou Medical Insurance" has benefited 18,000 families since its launch in 2023, with total claims amounting to 251 million yuan [2] - The program covers a wide age range, from newborns to individuals aged 105, indicating an expanding coverage scope [2] - The 2026 version will enhance the existing coverage by lowering claim thresholds and introducing a one-time hospitalization subsidy [2] Group 2: Coverage Options - The 2026 "Zhengzhou Medical Insurance" offers two coverage plans: "Basic Version" and "Upgraded Version," with the same premium rates as the previous year [3] - The "Basic Version" costs 89 yuan per person annually, providing a maximum annual coverage of 2.3 million yuan, while the "Upgraded Version" costs 169 yuan with a maximum coverage of 2.9 million yuan [3] - The "Upgraded Version" features lower reimbursement thresholds and higher reimbursement rates, including coverage for overseas specialty drugs and advanced treatments [3] Group 3: Accessibility - The program is designed to have broad coverage with no entry barriers, allowing participation regardless of age, residency, occupation, or health status, as long as individuals have basic medical insurance in Zhengzhou [4] - Enrollment for the 2026 "Zhengzhou Medical Insurance" will be available through various official channels, with two enrollment periods leading to different coverage start dates [4]

Core Insights - The insurance industry in Shaanxi Province is projected to achieve a total premium income of 141.17 billion yuan by the end of 2025, marking a year-on-year growth of 5.81%, which is an increase of 1.18 percentage points compared to the same period in 2024 [1] - Total claims expenditure across various insurance types is expected to reach 57.36 billion yuan, reflecting a year-on-year increase of 7.3% [1] - The industry will provide risk protection amounting to 94.67 trillion yuan, with property insurance contributing an additional coverage of 82.07 trillion yuan and life insurance adding 12.6 trillion yuan [1] Property Insurance Market - The property insurance sector is anticipated to generate a premium income of 35.73 billion yuan in 2025, with a year-on-year growth of 1.41% [2] - Motor vehicle insurance is expected to account for 22.56 billion yuan in premium income, showing a growth of 2.7%, and will provide risk protection of 29.33 trillion yuan [2] - New insurance products such as "Qin Family Insurance" and "Qin Science Insurance" have been successfully launched, enhancing coverage for technology and environmental risks [2] Life Insurance Market - The life insurance sector is projected to achieve a premium income of 105.43 billion yuan in 2025, with a year-on-year increase of 7.38% [3] - Total claims expenditure in the life insurance sector is expected to reach 33.62 billion yuan, reflecting a year-on-year growth of 13.63% [3] - Benefits paid out at maturity are projected to be 17.80 billion yuan, an increase of 2.04 billion yuan compared to the previous year, while annuity payments are expected to reach 9.04 billion yuan, up by 2.35 billion yuan [3]